美股异动｜再鼎医药盘前涨超3% 绩后获多家大行上调目标价

港股那点事03-04

格隆汇3月4日｜再鼎医药(ZLAB.US)盘前涨超3%，报32.7美元。消息面上，再鼎医药公布2024年度财报，总收入同比增加49.6%至3.99亿美元，主要是艾加莫德持续的强劲表现以及则乐和纽再乐销售收入持续增长。该公司预计2025年全年总收入将介于5.60亿至5.90亿美元之间，到第四季度实现非美国公认会计准则经营利润盈利。花旗将再鼎医药美股目标价由70美元轻微上调至71美元，给予“买入”评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2516562822?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-04 17:15","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2516562822","market":"us","top_or_hot":-1,"title":"美股异动｜再鼎医药盘前涨超3% 绩后获多家大行上调目标价","media":"港股那点事","content":"<div>\n<p>格隆汇3月4日｜再鼎医药(ZLAB.US)盘前涨超3%，报32.7美元。消息面上，再鼎医药公布2024年度财报，总收入同比增加49.6%至3.99亿美元，主要是艾加莫德持续的强劲表现以及则乐和纽再乐销售收入持续增长。该公司预计2025年全年总收入将介于5.60亿至5.90亿美元之间，到第四季度实现非美国公认会计准则经营利润盈利。花旗将再鼎医药美股目标价由70美元轻微上调至71美元，给予“买入”评级...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-03-04/doc-inennutp2725362.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股异动｜再鼎医药盘前涨超3% 绩后获多家大行上调目标价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股异动｜再鼎医药盘前涨超3% 绩后获多家大行上调目标价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-04 17:15 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/bxjj/2025-03-04/doc-inennutp2725362.shtml><strong>港股那点事</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇3月4日｜再鼎医药(ZLAB.US)盘前涨超3%，报32.7美元。消息面上，再鼎医药公布2024年度财报，总收入同比增加49.6%至3.99亿美元，主要是艾加莫德持续的强劲表现以及则乐和纽再乐销售收入持续增长。该公司预计2025年全年总收入将介于5.60亿至5.90亿美元之间，到第四季度实现非美国公认会计准则经营利润盈利。花旗将再鼎医药美股目标价由70美元轻微上调至71美元，给予“买入”评级...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-03-04/doc-inennutp2725362.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-03-04/doc-inennutp2725362.shtml","article_id":"2516562822","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516562822","pubTimestamp":1741079700,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"格隆汇3月4日｜再鼎医药盘前涨超3%，报32.7美元。花旗将再鼎医药美股目标价由70美元轻微上调至71美元，给予“买入”评级，相信今年的渠道数据、Vygart增长、越来越接近2026年KarXT推出的前景，应能重新激发投资者对该股的情绪。高盛将再鼎医药H股目标价从40.4港元上调至42.01港元，给予“买入”评级，重申2025年是再鼎医药发展里程碑年。中金将再鼎医药H股目标价上调22.5%至34.41港元，维持“跑赢大市”评级，留意到公司在今明两年有大量的催化剂。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"09688":"再鼎医药","ZLAB":"再鼎医药"},"translate_title":"Changes in U.S. stocks | Zai Lab rose more than 3% before the market, and after the results, many major banks raised their target prices","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1,"ZLAB":1},"content_text":"格隆汇3月4日｜再鼎医药(ZLAB.US)盘前涨超3%，报32.7美元。消息面上，再鼎医药公布2024年度财报，总收入同比增加49.6%至3.99亿美元，主要是艾加莫德持续的强劲表现以及则乐和纽再乐销售收入持续增长。该公司预计2025年全年总收入将介于5.60亿至5.90亿美元之间，到第四季度实现非美国公认会计准则经营利润盈利。花旗将再鼎医药美股目标价由70美元轻微上调至71美元，给予“买入”评级，相信今年的渠道数据、Vygart增长、越来越接近2026年KarXT推出的前景，应能重新激发投资者对该股的情绪。高盛将再鼎医药H股目标价从40.4港元上调至42.01港元，给予“买入”评级，重申2025年是再鼎医药发展里程碑年。中金将再鼎医药H股目标价上调22.5%至34.41港元，维持“跑赢大市”评级，留意到公司在今明两年有大量的催化剂。(格隆汇)               \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2516562822"}